{"id":80417,"date":"2025-11-14T09:26:08","date_gmt":"2025-11-14T09:26:08","guid":{"rendered":"https:\/\/www.europesays.com\/se\/80417\/"},"modified":"2025-11-14T09:26:08","modified_gmt":"2025-11-14T09:26:08","slug":"viktigaste-lakemedlet-vid-beroende-forsvinner","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/80417\/","title":{"rendered":"Viktigaste l\u00e4kemedlet vid beroende f\u00f6rsvinner"},"content":{"rendered":"

Det fr\u00e4msta l\u00e4kemedlet mot opioidberoende, Subutex, kommer inom kort att helt att f\u00f6rsvinna fr\u00e5n Sverige, skriver Aftonbladet. Detta eftersom tillverkaren Indivior har meddelat att f\u00f6retaget l\u00e4mnar den svenska marknaden. <\/p>\n

Beskedet bekymrar Joar Guterstam, forskare och beroendel\u00e4kare p\u00e5 Karolinska Institutet. <\/p>\n

\u2013 Det h\u00e4r blir ju en n\u00f6dsituation. Vi m\u00e5ste prioritera om helt och snabbt pr\u00f6va ut alternativ, s\u00e4ger han. <\/p>\n

L\u00e4kemedelsverket uppger att uppgifterna \u00e4r nya och \u00e4nnu inte har hunnit utredas. Enligt gruppchefen Maria Wanlund finns liknande l\u00e4kemedel som inte \u00e4r lika starka men som borde g\u00e5 att anv\u00e4nda som ers\u00e4ttning. <\/p>\n

Omni \u00e4r politiskt obundna och oberoende. Vi str\u00e4var efter att ge fler perspektiv p\u00e5 nyheterna. Har du fr\u00e5gor eller synpunkter kring v\u00e5r rapportering? Kontakta redaktionen<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Det fr\u00e4msta l\u00e4kemedlet mot opioidberoende, Subutex, kommer inom kort att helt att f\u00f6rsvinna fr\u00e5n Sverige, skriver Aftonbladet. Detta…\n","protected":false},"author":2,"featured_media":80418,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[22,23,26,27,17,21,5686,24,25,28,29,15,16,18,34,31,33,32,30,19,20,330],"class_list":{"0":"post-80417","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-rubriker","8":"tag-breaking-news","9":"tag-breakingnews","10":"tag-featured-news","11":"tag-featurednews","12":"tag-headlines","13":"tag-huvudnyheter","14":"tag-lakemedelsverket","15":"tag-latest-news","16":"tag-latestnews","17":"tag-main-news","18":"tag-mainnews","19":"tag-news","20":"tag-nyheter","21":"tag-rubriker","22":"tag-se","23":"tag-svenska","24":"tag-sverige","25":"tag-sweden","26":"tag-swedish","27":"tag-top-stories","28":"tag-topstories","29":"tag-vard-omsorg"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115547339708778097","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/80417","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=80417"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/80417\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/80418"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=80417"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=80417"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=80417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}